Human Sperm Markers of Cryodamage Resistance

Sponsor
Instituto Valenciano de Infertilidad, IVI Alicante (Other)
Overall Status
Completed
CT.gov ID
NCT02535377
Collaborator
Igenomix (Industry)
40
1
58
0.7

Study Details

Study Description

Brief Summary

Sperm freezing has been employed for decades for male fertility preservation in cases of foreseeable or unexpected loss of fertility to guarantee future paternity, and also as a complement of assisted reproduction techniques.

Sperm quality after thawing is highly variable, even among consecutive samples from the same individual, with mean survival rates around 40%. To date, the molecular basis of the adequate resistance or intolerance to freezing/thawing protocols is unknown, and its knowledge can lead to improvement in the selection of the samples to be frozen and also in the adequate supplement of cryopreservation media. Microarray analysis provides a powerful tool to address the molecular explanation beyond this behaviour, yielding results about comparative messenger ribonucleic acid (mRNA)expression under the two different biological conditions: optimal and suboptimal survival.

Then, the aim of the investigators' study is to determine the genomic profile of sperm samples depending on their survival resistance to cryopreservation, to determine genes involved in cryodamage sensitivity.

Condition or Disease Intervention/Treatment Phase
  • Other: Sperm cryopreservation

Detailed Description

Nested cases and controls design, with donor sperm samples frozen under conventional protocols, categorized depending on their good (GSR, n=20) (less than 20% motility decrease) or bad (BSR, n=20) (more than 20% motility decrease) survival rates. Sperm mRNA was extracted using Trizol protocol, suspended in diethylpyrocarbonate (DEPC)-treated water and frozen at -80 degrees until the microarray experiments were performed. RNAs were analyzed on Agilent Bioanalyzer 2100. Samples were pooled in 4 (5 samples/pool and 4 pools/group). Finally, 8 Agilent One colour Whole genome microarray (44K) were performed with pooled samples, 4 microarrays per group.

The results will be evaluate to detect those genes differentially expressed.

Study Design

Study Type:
Observational
Actual Enrollment :
40 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Molecular Diagnostic of Sperm Cryoresistance of Semen Donors and Clinical Outcomes After Artificial Insemination. Optimization of Sperm Bank
Study Start Date :
Feb 12, 2015
Actual Primary Completion Date :
Nov 12, 2018
Actual Study Completion Date :
Dec 12, 2019

Arms and Interventions

Arm Intervention/Treatment
High cryoresistance

High resistance to sperm cryopreservation (decreased sperm motility <20%)

Other: Sperm cryopreservation
Sperm from the different groups are cryopreserved to evaluate their resistance to preservation.

Low cryoresistance

Low resistance to sperm cryopreservation (decreased sperm motility >20%)

Other: Sperm cryopreservation
Sperm from the different groups are cryopreserved to evaluate their resistance to preservation.

Outcome Measures

Primary Outcome Measures

  1. Genomic profile of sperm samples depending on their survival resistance to cryopreservation [A year and a half]

    The genomic profile of sperm samples depending on their survival resistance to cryopreservation will be analysed and expressed as: Common or differentially expressed genes: in case of genes expressed in both groups Exclusive Genes, in case of genes expressed just in one group

Secondary Outcome Measures

  1. Pregnancy rates after artificial insemination with donor semen in the different groups. [two years]

    Once obtained the genomic profile of samples from donors included the different groups, we will analyze its relationship with the reproductive outcomes, in particular pregnancy rates after conventional artificial insemination (percentage of positive pregnancy test)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
The criteria used for the inclusion of donors in the sperm bank will be considered:
  • males from 18 to 35 years.

  • good physical and psychological conditions and no hereditary diseases

  • seminal parameters: concentration > 40 million sperm / ml; percentage of progressive motility> 50% percentage of normal forms> 4%.

  • For pregnancy rates after artificial insemination, only women< 40 years without tubal pathologies and artificial insemination indications will be included.

Exclusion Criteria:

All the population not included in the list of inclusion will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 IVI Alicante Alicante Spain 03015

Sponsors and Collaborators

  • Instituto Valenciano de Infertilidad, IVI Alicante
  • Igenomix

Investigators

  • Principal Investigator: Elena Sellés, PhD, Instituto Valenciano de Infertilidad, IVI Alicante

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Elena Sellés Soriano, Molecular diagnostic of sperm cryoresistance of semen donors and clinical outcomes after artificial insemination. Optimization of sperm bank, Instituto Valenciano de Infertilidad, IVI Alicante
ClinicalTrials.gov Identifier:
NCT02535377
Other Study ID Numbers:
  • 1406-ALC-048-ES
First Posted:
Aug 28, 2015
Last Update Posted:
Feb 10, 2021
Last Verified:
Jan 1, 2020
Keywords provided by Elena Sellés Soriano, Molecular diagnostic of sperm cryoresistance of semen donors and clinical outcomes after artificial insemination. Optimization of sperm bank, Instituto Valenciano de Infertilidad, IVI Alicante

Study Results

No Results Posted as of Feb 10, 2021